NCT00128063View on ClinicalTrials.gov

Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

June 30, 2006

Conditions

HIV Infections

Interventions

DRUG

succinylated human serum albumin

Trial Locations (1)

1105AZ

Academic Medical Center, University of Amsterdam, Amsterdam

Sponsors

Collaborators (1)

Prothya Biosolutions

All Listed Sponsors

collaborator

University Medical Center Groningen

OTHER

collaborator

Prothya Biosolutions

INDUSTRY

lead

International Antiviral Therapy Evaluation Center

OTHER

NCT00128063 - Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection | Biotech Hunter | Biotech Hunter